Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine
- PMID: 28250003
- PMCID: PMC5394976
- DOI: 10.3324/haematol.2016.156000
Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine
Figures



Similar articles
-
Current use of biologicals in thrombosis and haemostasis.Thromb Haemost. 2008 May;99(5):805-6. doi: 10.1160/TH08-04-0201. Thromb Haemost. 2008. PMID: 18449409 No abstract available.
-
Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?Thromb Res. 2016 Aug;144:133-5. doi: 10.1016/j.thromres.2016.05.024. Epub 2016 May 25. Thromb Res. 2016. PMID: 27331346 No abstract available.
-
Personalized medicine in thrombosis: back to the future.Blood. 2016 Jun 2;127(22):2665-71. doi: 10.1182/blood-2015-11-634832. Epub 2016 Feb 4. Blood. 2016. PMID: 26847245 Free PMC article. Review.
-
Lifestyle Genomics: Addressing the Multifactorial Nature of Personalized Health.Lifestyle Genom. 2018;11(1):1-8. doi: 10.1159/000492297. Epub 2018 Jul 26. Lifestyle Genom. 2018. PMID: 30048966 No abstract available.
-
Fibrinogen and Fibrin in Hemostasis and Thrombosis.Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):e13-e21. doi: 10.1161/ATVBAHA.117.308564. Arterioscler Thromb Vasc Biol. 2017. PMID: 28228446 Free PMC article. Review. No abstract available.
Cited by
-
Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.Intern Emerg Med. 2018 Jun;13(4):463-465. doi: 10.1007/s11739-018-1829-7. Epub 2018 Mar 14. Intern Emerg Med. 2018. PMID: 29541919 No abstract available.
-
Next-generation strategies to improve safety and efficacy of adeno-associated virus-based gene therapy for hemophilia: lessons from clinical trials in other gene therapies.Haematologica. 2024 Dec 1;109(12):3879-3891. doi: 10.3324/haematol.2023.284622. Haematologica. 2024. PMID: 38450517 Free PMC article. Review.
-
Digital Personal Health Coaching Platform for Promoting Human Papillomavirus Infection Vaccinations and Cancer Prevention: Knowledge Graph-Based Recommendation System.JMIR Form Res. 2023 Nov 15;7:e50210. doi: 10.2196/50210. JMIR Form Res. 2023. PMID: 37966885 Free PMC article.
-
Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders.J Blood Med. 2021 Oct 21;12:897-911. doi: 10.2147/JBM.S325031. eCollection 2021. J Blood Med. 2021. PMID: 34707421 Free PMC article.
-
Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.Int J Mol Sci. 2022 May 6;23(9):5213. doi: 10.3390/ijms23095213. Int J Mol Sci. 2022. PMID: 35563604 Free PMC article. Review.
References
-
- Kurnik K, Kreuz W, Horneff S, et al. Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children–results of a multicenter study. Haematologica. 2007;92(7):982–985. - PubMed
-
- Franchini M, Lippi G. Factor V Leiden and hemophilia. Thromb Res. 2010;125(2):119–123. - PubMed
-
- Shaw JA, Cooper ME. Guidelines and their use in clinical practice. Diab Vasc Dis Res. 2014;11(1):3–4. - PubMed
-
- Illing PT, Mifsud NA, Purcell AW. Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions. Curr Opin Immunol. 2016;42:31–40. - PubMed
-
- Reach G. Clinical inertia, uncertainty and individualized guidelines. Diabetes Metab. 2014;40(4):241–245. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical